Escherichia coli vaccine

Drug Profile

Escherichia coli vaccine

Alternative Names: ETEC vaccine - Berna Biotech; Traveller's diarrhoea vaccine - Berna Biotech

Latest Information Update: 12 Oct 2006

Price : $50

At a glance

  • Originator Berna Biotech
  • Class Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Escherichia coli infections

Most Recent Events

  • 24 Jul 2001 The Swiss Serum and Vaccine Institute Berne is now called Berna Biotech
  • 07 Jul 1999 A study has been added to the Bacterial Infections immunogenicity section
  • 14 Apr 1998 A clinical study has been added to the Bacterial Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top